Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanna Therapeutics Ltd.

www.nannatherapeutics.com

Latest From Nanna Therapeutics Ltd.

Deal Watch: Genentech Gets Down In The Dirt With Lodo Therapeutics

Genentech and Lodo will mine the soil microbiome to discover novel therapeutics. China’s Luye licenses commercial rights to AstraZeneca’s Seroquel franchise, while Sarepta picked up rights to gene therapy candidates from Myonexus, plus an option to acquire the company.
Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Inflammation
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Bactevo Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Nanna Therapeutics Ltd.
  • Senior Management
  • David Williams, PhD, CEO
    John Wain, Prof, CSO
    Alex Alanine, PhD, COO
    Stuart Wood, PhD, CTO
    Nicki Thompson, PhD, CBO
  • Contact Info
  • Nanna Therapeutics Ltd.
    Phone: 1223 423506
    The Merrifield Centre
    Rosemary Lane
    Cambridge, CB1 3LQ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register